Biota Pharmaceuticals IncAdd to My Watchlist

BOTA:USNASDAQ GSIndustry: Medical-Biomedical/Gene
  • 1.37
    Last
  • 0.05  -3.52%
    Today's Change
  • 1.42
    Previous Close
  • Today
     
    1.23
    2.67
    52 Week Low - High
8:10 pm ET 2/11/2016
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding39 million
Market Cap$53 million
Return on Equity ttm-45.46%
Last Dividend$6.65
Dividend Yield ttm--
Relative Dividend Yield benchmark--
Dividend Ex-Date11/9/12
Dividend Pay Date11/8/12
Earnings
EPS: Year Actual ttm-0.540
EPS: Year Est. 6/16 ttm-0.700
 
EPS: Quarterly Actual 12/15 -0.17
EPS: Quarterly Est. 3/16 -0.18
 
Price/Earnings ttm--
Relative Price/Earnings--
Earnings Growth Rate-54.29
Company Description
Biota Pharmaceuticals Inc is an anti-infective drug development company with expertise in respiratory diseases, particularly influenza. The Company developed the first neuraminidase inhibitor. Biota's research breakthroughs include a series of candidate drugs aimed at treatment of respiratory syncytial virus (RSV) disease and Hepatitis C (HCV) virus infections.
Revenue$25 million
Net Income$-19 million
Total Assets$79 million
Employees19
Web Sitewww.biotapharma.com

Latest Headlines

No news available.

    Watchlist

    Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

    Sign In Now

     

    Not Registered?

    Get complete access to The Washington Post online - it's FREE!